First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors Meeting Abstract
| Authors: | Goyal, L.; Subbiah, V.; Mahipal, A.; Kamath, S.; Mody, K.; Borad, M.; El-Khoueiry, A.; Sahai, V.; Kim, R.; Kelley, R.; Schmidt-Kittler, O.; Shen, J.; Jen, K.; Deary, A.; Padval, M.; Sherwin, C.; Wolf, B.; Schram, A. |
| Abstract Title: | First-in-human study of highly selective FGFR2 inhibitor, RLY-4008, in patients with intrahepatic cholangiocarcinoma and other advanced solid tumors |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S120 |
| Language: | English |
| ACCESSION: | WOS:000670004200070 |
| DOI: | 10.1016/j.annonc.2021.05.125 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P-70 -- Source: Wos |
